Trials / Completed
CompletedNCT05617976
Nalbuphine as an Adjuvant to Levobupivacaine in Caudal Analgesia in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 1 Year – 3 Years
- Healthy volunteers
- Not accepted
Summary
Caudal anesthesia is the single most important pediatric regional anesthetic technique and is increasingly performed in pediatric regional anesthesia practices. It is preferred in order to relieve intra-operative and postoperative pain in children of all age groups undergoing pelvi-abdominal or lower limbs surgeries using levobupivacaine 0.25%.Various adjuvants have been added to levobupivacaine to prolong postoperative caudal analgesia. Nalbuphine as many opioids can be added in caudal analgesia. This prospective randomized double blind study was done to compare the effects of plain levobupivacaine versus Levobupivacaine plus nalbuphine single-shot for postoperative pain relief in children undergoing hypospadius repair surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | caudal block | caudal block |
Timeline
- Start date
- 2020-10-04
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2022-11-16
- Last updated
- 2022-11-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05617976. Inclusion in this directory is not an endorsement.